有氧运动对高血压合并糖尿病患者血小板功能的影响被引量：6

Effects of Aerobic Exercise on Platelet Function in Patients with Hypertension and Type 2 Diabetes

导出

摘要目的探讨有氧运动对高血压合并2型糖尿病患者血小板功能状态影响。方法门诊就诊的高血压合并2型糖尿病患者51例随机分为2组,常规治疗组26例,规律运动组25例,后者在常规治疗的基础上采取中等量的运动疗法3个月。放射免疫法测定血栓素B2(TXB2)及6-酮-前列腺素1α(6-keto-PGF1α)。流式细胞技术(FCM)以单克隆抗体分子作为探针,测定血小板膜上CD62P、CD61的阳性百分率(%)。结果运动疗法3个月后,实验组与对照组2组比较,TXB2明显降低(P<0.05);6-keto-PGF1α明显升高(P<0.01);血小板膜上CD62P阳性百分率(%)及、CD61阳性百分率(%)及血小板聚集率(%)均明显降低(P<0.05)。结论规律运动降低高血压合并2型糖尿病患者的血小板表面活化受体分子密度及血小板聚集率,减轻高血压合并2型糖尿病患者的血栓前状态。 Objective To explore the effects of aerobic exercise on platelet function in patients with hypertension and type 2 diabetes. Methods 51 patients with hypertension and type 2 diabetes were divided into exercise group （n = 25） and control group （n = 26）. The exercise with moderate intensity was 30 rain per session, 5 sessions per week for 3 months. The platelet membrane glycoprotein CD62P, CD61 （ Ⅲ a） were determined by flow cytometric analysis and platelet aggregating ratio measured before and after regular aerobic exercise. Results After three months of aerobic exercise, TXB2 （pg/mL）（ 144.2± 5.6 vs 111.3 ± 6.8, P 〈 0.05）, 6-keto-PGF1a（pg/mL）（96.1±4.7 vs 120.6 ± 6.3, P 〈 0.01）, the positive percent of platelet membrane glycoproten CD62P（%）（27.3±2.2 vs 20.5±3.8, P〈0.05）, CD61（Ⅲa）（%）（28.3Ⅲ3.3 vs21.2Ⅲ4.8, P 〈 0.05） and platelet aggregating ratio（ % ）（81.3 Ⅲ 4.1 vs 73.1 Ⅲ 4.3, P 〈 0.05 ） in aerobic exercise group decreased significantly compared with those of the control group. Conclusions Regular aerobic exercise can decrease the positive percent of platelet membrane glycoprotein and platelet aggregating ratio in patients with hypertension and type 2 diabetes.

作者李玉峰王士雯赵玉生卢才义薛桥

机构地区解放军总医院老年心血管病研究所老年心血管病救治中心

出处《实用临床医药杂志》 CAS 2007年第1期42-44,共3页 Journal of Clinical Medicine in Practice

基金中央保健委员会专项基金重点资助课题(B020)

关键词高血压病有氧运动 2型糖尿病血小板膜糖蛋白受体 hypertension type 2 diabetes aerobic exercise platelet membrane glycoprotein

分类号 R411.712 [医药卫生—临床医学] R415.382 [医药卫生—临床医学]

引文网络
相关文献

参考文献9

1Sowers J R,Epstein M,Frohlich E D.Diabetes,hypertension and cardiovascular disease[J].Hypertension,2001,37:1053.
2Andre P,Alaimo L,Prasad S K,et al.Platelet-derived CD40L:the switch-hitting player of cardiovascular disease[J].Circulation,2002,106:896.
3Lip G Y,Bland A D.Does hypertension confer a prethrombotic state,Virchow'strial revisited[J].Circulation,2002,101:218.
4Sreedlara R,Itagaki I,Hakim R M.Uremic patients have induced platelet aggregation mediated by decreased availability of glycoprotein Ⅱb/Ⅲa receptors[J].Am J Kindey,1996,27:355.
5汪钟.现代血栓病学[J].北京:中国医科大学协和医科大学联合出版社,1996.191.
6夏珂,杨天崙.高血压导致血小板活化的机制[J].国外医学（生理病理科学与临床分册）,2005,25(2):120-123. 被引量：9
7Maeda S,Tanabe T,Miyauchi T,et al.Aerobic exercise training reduces plasma endothelin-1 concentration in older women[J].J Appl Physiol,2003,95(1):336.
8Wang J S,Jen C J,Chen H I.Effects of chronic exercise and deconditioning on platelet function in women[J].J Appl physiol,1997,83(67):2080.
9Conway D S,Pearce L A.Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation[J].Circulation,2002,106:1962.

二级参考文献20

1Breddin HK, Lippold R, Bittner M, et al. Spontaneous platelet aggregation as a predictive risk factor for vascular occlusions in healthy volunteers? Results of the HAPARG study [J]. Atherosclerosis, 1999,144( 1 ) :211-219.
2Nadar S, Blann AD, Lip GY. Platelet morphology and plasma indices of platelet activation in essential hypertension : effects of analedipine-based antihypertensive therapy [J]. Ann Med,2004, 36 (7) :552-557.
3Behrendt D, Ganz P. Endothelial function:From vascular biology to clinical applications [J]. Am J Cardiol, 2002,90 (suppl) :40-48.
4Egashira K. Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease[J]. Circ J,2002,66(6) :529-533.
5Jagroop IA, Clatworthy I, Lewin J, et al. Shape change in human platelets:measurement with a channelyzer and visualisation by electron microscopy [ J ]. Platelets ,2000,11 ( 1 ) : 28 -32.
6Molero L, Farre J, Garcia-Mendez A, et al. Endothelin-1 induced proinflammatory markers in the myocardium and leukocytes of guineapigs: role of glycoprotein IIB/IIIA receptors [J]. Cardiovasc Res,2003,57( 1 ) :109-118.
7Jagroop IA, Mikhailidis DP. Effect of endothelin-1 on human platelet shape change: reversal of activation by naftidrofuryl [J]. Platelets,2000,11 (5) :272-277.
8Leung SW, Man GS, Man RY. Platelet-activating factor enhanced the pressor response of endothelin-1 [J]. J Cardiovasc Pharmacol,2002, 40(4) :528-532.
9Michaux G, Cutler DF. How to roll an endothelial cigar: the biogenesis of weibel-palade bodies[J]. Traffic,2004, 5(2) :69-78.
10Clutton P, Folts JD, Freedman JE. Pharmacological control of platelet function[J]. Pharmaco Res,2001,44(4) :255-264.